引用本文:李 博.依达拉奉与舒血宁联合治疗脑梗死的临床疗效分析[J].中国临床新医学,2015,8(5):443-445.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1543次   下载 1287 本文二维码信息
码上扫一扫!
分享到: 微信 更多
依达拉奉与舒血宁联合治疗脑梗死的临床疗效分析
李 博
518112 广东,深圳市龙岗区第二人民医院内一科
摘要:
[摘要] 目的 探讨依达拉奉与舒血宁联合治疗脑梗死的临床疗效。方法 选取入住该院脑梗死患者146例,随机分为依达拉奉组和联合组各73例,分别采用依达拉奉、依达拉奉联合舒血宁治疗,评价治疗效果。结果 2个疗程后,联合组患者神经功能评分[(79.29±21.03) vs (69.24±18.15)]、生活能力评分[(59.42±18.03) vs (30.24±12.38)]均优于依达拉奉组(P<0.05);联合组临床疗效高于依达拉奉组(P<0.05)。结论 依达拉奉与舒血宁联合治疗脑梗死能够有效改善患者神经功能和生活能力,提高临床疗效。
关键词:  依达拉奉  舒血宁  脑梗死
DOI:10.3969/j.issn.1674-3806.2015.05.17
分类号:R 743.3
基金项目:
Analysis of clinical efficacy of edaravone combined with Shuxuening injection in the treatment of cerebral infarction
LI Bo
Department of Internal Medicine, the Second People′s Hospital of Longgang District, Shenzhen 518112, China
Abstract:
[Abstract] Objective To investigate the clinical efficacy of edaravone combined with Shuxuening injection in treatment of cerebral infarction.Methods 146 patients with cerebral infarction were randomly divided into edaravone group and combination group, being treated with edaravone and edaravone combined with Shuxuening injection respectively.Results After 2 months′treatment, the scores of the combination group and the edaravone group were [(79.29±21.03) vs (69.24±18.15)]. The scores of life ability recovery degree in the two groups were [(59.42±18.03) vs (30.24±12.38)](P<0.05); The efficiency of the combination group was higher than that of the edaravone group(P<0.05).Conclusion Edaravone combined with Shuxuening injection improves nerve function in the cerebral infarction patients with nerve injury and increases the their self-care ability and treatment efficient rate.
Key words:  Edaravone  Shuxuening injection  Cerebral infarction